Start / The Hematologist / Venous thromboembolism risk markers and discontinuing combined hormonal contraceptives

The Hematologist

Venous Thromboembolism Risk Markers and Discontinuing Combined Hormonal Contraceptives

26 min • 7 maj 2024

In this episode, Contributing Editor Samuel Wilson, MD, an assistant professor of hematology at the University of North Carolina, Chapel Hill, talks with Marc Blondon, MD, an attending physician in the division of angiology and hemostasis with the University Hospitals of Geneva (Switzerland). They talk about a paper co-authored by Dr. Blondon titled, “Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives.” Dr. Wilson wrote about the study in a recent issue of The Hematologist.

Senaste avsnitt

More Than Medicine: Peer Connection as a Therapeutic Adjunct in Acute Leukemia

28 juli | 23 min

Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia

23 juni | 22 min

Dual BCR::ABL1 Inhibition Shows Promise in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

24 maj | 19 min

When to STOP Treatment for Immune Thrombocytopenia in Patients Experiencing a Complete Response on Thrombopoietin Receptor Agonists

16 maj | 11 min

No Scientific Link Found Between Sickle Cell Trait and Sudden Death

28 april | 21 min

Podcastbild

00:00 -00:00

Podcastbild

00:00 -00:00